COVID-19
|
SUBSCRIBE
|
FAQs
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
TEST KITS
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
TEST KITS
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
Test
Safety alerts
MSA Gamma Benzine Hexachloride
MEDICINE SAFETY ALERT: NEW RESTRICTIONS ON THE USE OF GAMMA BENZENE HEXACHLORIDE (LINDANE) – CONTAINING SHAMPOOS
May 2009
MSA Rotarix
The Medicines Control Council (MCC) alerts all health care professionals to the correct route of administration of Rotarix vaccine.
March 2008
MSA Ketoconazole And Domperidone
MEDICINE SAFETY ALERT: INTERACTION BETWEEN KETOCONAZOLE AND DOMPERIDONE AND THE RISK OF QT PROLONGATION
March 2008
MSA promethazine
The Medicines Control Council (MCC) alerts all health care professionals to new prescribing information for promethazine.
September 2007
MSA cough and cold medicines
MEDICINE SAFETY ALERT: COUGH AND COLD MEDICINE NO LONGER TO BE USED ON CHILDREN UNDER THE AGE OF TWO YEARS
June 2012
MSA atypical antipsychotics
MEDICINE SAFETY ALERT: ATYPICAL ANTIPSYCHOTICS IN ELDERLY PATIENTS WITH DEMENTIA
June 2009
DHCPL for ACE-inhibitor/Angiotensin receptor blocker containing medicines
ACUTE KIDNEY INJURY (AKI) ASSOCIATED WITH CONCOMITANT USE, ESPECIALLY IN INDIVIDUALS WITH MODERATE TO SEVERE RENAL IMPAIRMENT AND ELDERLY PATIENTS.
25 September 2009